STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy
Novartis has acknowledged seven previously unknown instances in which tumors were found in children who were treated with its spinal muscular atrophy therapy, Zolgensma.
Reported by STAT. We will add other newspapers as they cover it.
How the newspaper covers this story
STAT+: A possible comeback for a failed sickle cell gene therapy
Three years ago, a trial for a sickle cell gene-editing therapy a decade in the making ended abruptly after the first patient suffered a serious adverse event. Now, the therapy…
· STAT+: Novartis cites cases of previously unknown tumors possibly tied to its SMA gene therapy
· STAT+: Pharmalittle: We’re reading about a Novartis gene therapy, faster U.K. drug reviews, and more
· STAT+: Zolgensma tumor cases show risks of a common gene therapy tool
